AndrewCVon EschenbachMD

Urology • Montgomery, TX

Professor, Surgery, Uniformed Services Hebert SOM

Join to view full profile

Are you Dr. Von Eschenbach?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 16 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
163 Sarasota Cir S
Montgomery, TX 77356
Phone+1 936-597-8370

Fax+1 936-597-5495
Is this information wrong?

Summary

Dr. Andrew Von Eschenbach, MD is a board certified urologist in Montgomery, Texas. He is currently licensed to practice medicine in Texas and Pennsylvania. He is a Professor at Uniformed Services Hebert SOM.

Education & Training

Georgetown University School of MedicineClass of 1967

Certifications & Licensure

TX State Medical License 1977 - 2024
PA State Medical License 1971 - 1978
American Board of Urology Urology

Awards, Honors, & Recognition

Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Roundtable--the changing oncology landscape: evolution or revolution?
Beveridge R, Fox J, Higgins SA, Kohn M, Mahoney JJ, Newcomer LN, von Eschenbach A, Goodman C> ;J Natl Compr Canc Netw. 2013-05-01
1 citations
Expediting the availability of drugs for US patients with cancer.
Ann T. Farrell, Richard Pazdur, Andrew C von Eschenbach> ;Nature Clinical Practice. Urology. 2008 Dec 1
1 citations
The FDA Amendments Act: reauthorization of the FDA.
Andrew C von Eschenbach> ;Food and Drug Law Journal. 2008 Jan 1
3 citations
Eliminating error-prone notations in medical communications
Andrew C von Eschenbach> ;Expert Opinion on Drug Safety. 2007 May 4
18 citations
The Biomarkers Consortium: public and private sectors working in partnership to improve the public health.
Elias A. Zerhouni, Charles A. Sanders, Andrew C von Eschenbach> ;The Oncologist. 2007 Mar 1
Cancer informatics vision: caBIG.
von Eschenbach AC, Buetow K> ;Cancer Inform. 2007-02-06
State of the FDA.
von Eschenbach Ac> ;Food and Drug Law Journal. 2007 Jan 1
2 citations
Progress With a Purpose: Eliminating Suffering and Death Due to Cancer
Andrew C von Eschenbach> ;Oncology. 2006 Nov 17
The future of protecting and promoting public health.
von Eschenbach, A.C.> ;FDA Consum. 2006-01-01
4 citations
Keynote speech: Progress with a purpose
Andrew C. von Eschenbach> ;Cancer. 2005 Dec 15
34 citations
A vision for the National Cancer Program in the United States.
Andrew C. von Eschenbach> ;Nature Reviews. Cancer. 2004 Oct 1
Andrew C. von Eschenbach, MD, director, National Cancer Institute.
von Eschenbach AC> ;J. Investig. Med.. 2004-01-01
22 citations
NCI sets goal of eliminating suffering and death due to cancer by 2015.
Andrew C. von Eschenbach> ;Journal of the National Medical Association. 2003 Jul 1
Introductory comments: models of anti-cancer therapy.
Von Eschenbach, A.C.> ;Cancer Biol Ther. 2003-07-01
83 citations
Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
Alan Pollack, Didier Cowen, Patricia Troncoso, Gunar K. Zagars, Andrew C. von Eschenbach, Marvin L. Meistrich, Timothy J. McDonnell> ;Cancer. 2003 Apr 1
1018 citations
PROSTATE CANCER RADIATION DOSE RESPONSE: RESULTS OF THE M. D. ANDERSON PHASE III RANDOMIZED TRIAL
Alan Pollack, Gunar K. Zagars, George Starkschall, John A. Antolak, J. Jack Lee, Eugene Huang, Andrew C. von Eschenbach, Deborah A. Kuban, Isaac I. Rosen> ;International Journal of Radiation Oncology, Biology, Physics. 2002 Aug 1
Collaboration to play key role in NCI's future, director says. Interview by Katherine Arnold.
von Eschenbach A> ;J. Natl. Cancer Inst.. 2002-06-05
106 citations
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiotherapy: Variables Affecting Patient Outcome
Jonathan I. Izawa, Lydia T. Madsen, Shellie M. Scott, Jean Paul Tran, Edward J. McGuire, Andrew C. von Eschenbach, Louis L. Pisters> ;Journal of Clinical Oncology. 2002 Jun 1
14 citations
NCI remains committed to current mammography guidelines.
Andrew C. von Eschenbach> ;The Oncologist. 2002 Jun 1
62 citations
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapy.
Didier Cowen, Patricia Troncoso, V. Khoo, Gunar K. Zagars, Andrew C. von Eschenbach, Marvin L. Meistrich, Alan Pollack> ;Clinical Cancer Research. 2002 May 1
1 citations
Counseling patients about prostate cancer screening.
Lewis E. Foxhall, Andrew C. von Eschenbach> ;American Family Physician. 2002 May 1
American Cancer Society guidelines for the early detection of cancer.
Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ> ;CA Cancer J Clin. 2002-01-01
92 citations
SPERMATIC CORD SARCOMA: OUTCOME, PATTERNS OF FAILURE AND MANAGEMENT
Matthew T. Ballo, Gunar K. Zagars, Peter W.T. Pisters, Barry W. Feig, Shreyaskumar Patel, Andrew C. von Eschenbach> ;The Journal of Urology. 2001 Oct 1
83 citations
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancer.
Gunar K. Zagars, Alan Pollack, Andrew C. von Eschenbach> ;Urology. 2001 Aug 1
33 citations
LOCAL TUMOR CONTROL WITH SALVAGE CRYOTHERAPY FOR LOCALLY RECURRENT PROSTATE CANCER AFTER EXTERNAL BEAM RADIOTHERAPY
Jonathan I. Izawa, Paul Perrotte, Graham F. Greene, Shellie M. Scott, Lawrence B. Levy, Edward J. McGuire, Lydia T. Madsen, Andrew C. von Eschenbach, Louis L. Pisters> ;The Journal of Urology. 2001 Mar 1
Join now to see all